Charlotte's Web Holdings (CWBHF) Convertible Debt (2022 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Convertible Debt of $51.5 million for Q1 2026, up 15.09% year-over-year from $44.8 million in Q1 2025, and up 1.29% quarter-over-quarter from $50.8 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Convertible Debt (2022 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Convertible Debt for 5 consecutive years, with $51.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Convertible Debt rose 15.09% year-over-year to $51.5 million; the TTM figure through Mar 2026 stood at $51.5 million (up 15.09% YoY), while the FY2025 annual figure was $50.8 million, up 16.54% from the prior year.
- Convertible Debt climbed to $51.5 million in Q1 2026 per CWBHF's latest filing, from $50.8 million in the prior quarter.
- Across five years, Convertible Debt topped out at $51.5 million in Q1 2026 and bottomed at $37.4 million in Q4 2022.
- Historically, Convertible Debt has averaged $44.9 million across 5 years, with a median of $44.2 million in 2024.
- Annual changes were most pronounced in 2024 — Convertible Debt advanced 2.59% — and 2025, when it gained 16.54%.
- Charlotte's Web Holdings' Convertible Debt stood at $37.4 million in 2022, then gained by 13.65% to $42.5 million in 2023, then gained by 2.59% to $43.6 million in 2024, then grew by 16.54% to $50.8 million in 2025, then grew by 1.29% to $51.5 million in 2026.
- Business Quant data shows CWBHF's Convertible Debt at $51.5 million in Q1 2026, $50.8 million in Q4 2025, and $48.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.50 Mn |
| Dec 31, 2025 | 50.85 Mn |
| Sep 30, 2025 | 48.82 Mn |
| Jun 30, 2025 | 48.62 Mn |
| Mar 31, 2025 | 44.75 Mn |
| Dec 31, 2024 | 43.63 Mn |
| Mar 31, 2024 | 42.74 Mn |
| Dec 31, 2023 | 42.53 Mn |
| Mar 31, 2023 | 38.43 Mn |
| Dec 31, 2022 | 37.42 Mn |